Bart De Spiegeleer

Prof. Dr. Bart De Spiegeleer


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2018 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
YJYorick Janssens
Yorick Janssens
JNJoachim Nielandt
Joachim Nielandt
ABAntoon Bronselaer
Antoon Bronselaer
NDNathan Debunne
Nathan Debunne
FVFrederick Verbeke
Frederick Verbeke
BSBart De Spiegeleer
Bart De Spiegeleer
Recent research has provided fascinating indications and evidence that the host health is linked to its microbial inhabitants. Due to the development of high-throughput sequencing technologies, more and more data covering microbial composition changes in different disease types are emerging. However, this information is dispersed over a wide variety of medical and biomedical disciplines. Disbiome is a database which collects and presents published microbiota-disease information in a standardized way. The diseases are classified using the MedDRA classification system and the micro-organisms are linked to their NCBI and SILVA taxonomy. Finally, each study included in the Disbiome database is assessed for its reporting quality using a standardized questionnaire. Disbiome is the first database giving a clear, concise and up-to-date overview of microbial composition differences in diseases, together with the relevant information of the studies published. The strength of this database lies within the combination of the presence of references to other databases, which enables both specific and diverse search strategies within the Disbiome database, and the human annotation which ensures a simple and structured presentation of the available data.

14 October 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSSofie Stalmans
Sofie Stalmans
NBNathalie Bracke
Nathalie Bracke
EWEvelien Wynendaele
Evelien Wynendaele
BGBert Gevaert
Bert Gevaert
KPKathelijne Peremans
Kathelijne Peremans
BSBart De Spiegeleer
Bart De Spiegeleer
Cell-penetrating peptides (CPPs) are a group of peptides, which have the ability to cross cell membrane bilayers. CPPs themselves can exert biological activity and can be formed endogenously. Fragmentary studies demonstrate their ability to enhance transport of different cargoes across the blood-brain barrier (BBB). However, comparative, quantitative data on the BBB permeability of different CPPs are currently lacking. Therefore, the in vivo BBB transport characteristics of five chemically diverse CPPs, i.e. pVEC, SynB3, Tat 47–57, transportan 10 (TP10) and TP10-2, were determined. The results of the multiple time regression (MTR) analysis revealed that CPPs show divergent BBB influx properties: Tat 47–57, SynB3, and especially pVEC showed very high unidirectional influx rates of 4.73 μl/(g × min), 5.63 μl/(g × min) and 6.02 μl/(g × min), respectively, while the transportan analogs showed a negligible to low brain influx. Using capillary depletion, it was found that 80% of the influxed peptides effectively reached the brain parenchyma. Except for pVEC, all peptides showed a significant efflux out of the brain. Co-injection of pVEC with radioiodinated bovine serum albumin (BSA) did not enhance the brain influx of radiodionated BSA, indicating that pVEC does not itself significantly alter the BBB properties. A saturable mechanism could not be demonstrated by co-injecting an excess dose of non-radiolabeled CPP. No significant regional differences in brain influx were observed, with the exception for pVEC, for which the regional variations were only marginal. The observed BBB influx transport properties cannot be correlated with their cell-penetrating ability, and therefore, good CPP properties do not imply efficient brain influx.

12 April 2017 in Frontiers in Neuroscience
Verified
Journal Article
Open access
FVFrederick Verbeke
Frederick Verbeke
SCSeverine De Craemer
Severine De Craemer
NDNathan Debunne
Nathan Debunne
YJYorick Janssens
Yorick Janssens
EWEvelien Wynendaele
Evelien Wynendaele
BSBart De Spiegeleer
Bart De Spiegeleer
The expression of certain bacterial genes is regulated in a cell-density dependent way, a phenomenon called quorum sensing. Both Gram-negative and Gram-positive bacteria use this type of communication, though the signal molecules (auto-inducers) used by them differ between both groups: Gram-negative bacteria use predominantly N-acyl homoserine lacton (AHL) molecules (autoinducer-1, AI-1) while Gram-positive bacteria use mainly peptides (autoinducer peptides, AIP or quorum sensing peptides). These quorum sensing molecules are not only involved in the inter-microbial communication, but can also possibly cross-talk directly or indirectly with their host. This review summarizes the currently applied analytical approaches for quorum sensing identification and quantification with additionally summarizing the experimentally found in vivo concentrations of these molecules in humans.

1 July 2020 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
ASAnton De Spiegeleer
Anton De Spiegeleer
ABAntoon Bronselaer
Antoon Bronselaer
JTJames T. Teo
James T. Teo
GBGeert Byttebier
Geert Byttebier
Guy De TréGuy De Tré
Guy De Tré
BSBart De Spiegeleer
Bart De Spiegeleer

23 November 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
EWEvelien Wynendaele
Evelien Wynendaele
ABAntoon Bronselaer
Antoon Bronselaer
JNJoachim Nielandt
Joachim Nielandt
MDMatthias D’hOndt
Matthias D’hOndt
SSSofie Stalmans
Sofie Stalmans
BSBart De Spiegeleer
Bart De Spiegeleer
Quorum-sensing (QS) peptides are biologically attractive molecules, with a wide diversity of structures and prone to modifications altering or presenting new functionalities. Therefore, the Quorumpeps database (http://quorumpeps.ugent.be) is developed to give a structured overview of the QS oligopeptides, describing their microbial origin (species), functionality (method, result and receptor), peptide links and chemical characteristics (3D-structure-derived physicochemical properties). The chemical diversity observed within this group of QS signalling molecules can be used to develop new synthetic bio-active compounds.

1 December 2014 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MDMatthias D’hondt
Matthias D’hondt
NBNathalie Bracke
Nathalie Bracke
LTLien Taevernier
Lien Taevernier
BGBert Gevaert
Bert Gevaert
FVFrederick Verbeke
Frederick Verbeke
BSBart De Spiegeleer
Bart De Spiegeleer